Does denosumab offer survival benefits? —Our experience with denosumab in metastatic non-small cell lung cancer patients treated with immune-checkpoint inhibitors
@article{JTD54249,
author = {Yenong Cao and Muhammad Zubair Afzal and Keisuke Shirai},
title = {Does denosumab offer survival benefits? —Our experience with denosumab in metastatic non-small cell lung cancer patients treated with immune-checkpoint inhibitors},
journal = {Journal of Thoracic Disease},
volume = {13},
number = {8},
year = {2021},
keywords = {},
abstract = {},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/54249}
}